癌症与动脉粥样硬化中的免疫。
Immunity in cancer and atherosclerosis.
作者信息
Sima Petr, Vannucci Luca, Vetvicka Vaclav
机构信息
Laboratory of Immunotherapy, Institute of Microbiology, Academy of Sciences, Prague, Czech Republic.
Department of Pathology, University of Louisville, Louisville, KY, USA.
出版信息
Ann Transl Med. 2019 May;7(9):204. doi: 10.21037/atm.2019.04.56.
Abstract
Cancer and cardiovascular diseases have been classified as non-communicable diseases for decades. Both diseases have characteristics of immune reactions, which are principally identical, but differing in important aspects. The aim of this communication is to highlight new approaches to immune processes involved in both types of diseases.
摘要
几十年来，癌症和心血管疾病都被归类为非传染性疾病。这两种疾病都具有免疫反应特征，它们在本质上是相同的，但在重要方面存在差异。本交流的目的是强调涉及这两种疾病的免疫过程的新方法。
相似文献
1
Immunity in cancer and atherosclerosis.癌症与动脉粥样硬化中的免疫。
Ann Transl Med. 2019 May;7(9):204. doi: 10.21037/atm.2019.04.56.
2
Trained Innate Immunity as a Novel Mechanism Linking Infection and the Development of Atherosclerosis.训练有素的先天免疫作为感染与动脉粥样硬化发生发展相关的新机制。
Circ Res. 2018 Mar 2;122(5):664-669. doi: 10.1161/CIRCRESAHA.117.312465. Epub 2018 Jan 24.
3
Danger signaling in atherosclerosis.动脉粥样硬化中的危险信号。
Circ Res. 2015 Jan 16;116(2):323-40. doi: 10.1161/CIRCRESAHA.116.301135.
4
Humoral Immunity Against HDL Particle: A New Perspective in Cardiovascular Diseases?抗高密度脂蛋白粒子的体液免疫：心血管疾病的新视角？
Curr Pharm Des. 2019;25(29):3128-3146. doi: 10.2174/1381612825666190830164917.
5
Infections, immunity and atherosclerosis: pathogenic mechanisms and unsolved questions.感染、免疫与动脉粥样硬化：发病机制与未解问题
Int J Cardiol. 2013 Jul 1;166(3):572-83. doi: 10.1016/j.ijcard.2012.05.098. Epub 2012 Jun 22.
6
[Dendritic cells and their role in immune reactions of atherosclerosis].[树突状细胞及其在动脉粥样硬化免疫反应中的作用]
Tsitologiia. 2012;54(11):793-805.
7
Immunosurveillance and cancer: epidemiologic observations.免疫监视与癌症：流行病学观察
Natl Cancer Inst Monogr. 1977 Dec;47:121-6.
8
T cells, immunosurveillance, and cutaneous immunity.T细胞、免疫监视与皮肤免疫。
J Dermatol Sci. 2000 Dec;24 Suppl 1:S41-5. doi: 10.1016/s0923-1811(00)00140-7.
9
MicroRNAs and atherosclerosis: new actors for an old movie.微小 RNA 与动脉粥样硬化：旧剧中的新角色。
Nutr Metab Cardiovasc Dis. 2012 Nov;22(11):937-43. doi: 10.1016/j.numecd.2012.03.007. Epub 2012 Jun 28.
10
Long-term activation of the innate immune system in atherosclerosis.动脉粥样硬化中固有免疫系统的长期激活。
Semin Immunol. 2016 Aug;28(4):384-93. doi: 10.1016/j.smim.2016.04.004. Epub 2016 Apr 22.
引用本文的文献
1
Differential vascular endothelial cell toxicity of established and novel BCR-ABL tyrosine kinase inhibitors.已确立和新型 BCR-ABL 酪氨酸激酶抑制剂的血管内皮细胞毒性差异。
PLoS One. 2023 Nov 20;18(11):e0294438. doi: 10.1371/journal.pone.0294438. eCollection 2023.
2
A novel immune-related gene signature for predicting immunotherapy outcomes and survival in clear cell renal cell carcinoma.一种新型免疫相关基因标志物，用于预测透明细胞肾细胞癌的免疫治疗疗效和生存。
Sci Rep. 2023 Nov 2;13(1):18922. doi: 10.1038/s41598-023-45966-8.
3
Identification and verification of novel immune-related ferroptosis signature with excellent prognostic predictive and clinical guidance value in hepatocellular carcinoma.在肝细胞癌中鉴定和验证具有优异预后预测和临床指导价值的新型免疫相关铁死亡特征
Front Genet. 2023 Aug 21;14:1112744. doi: 10.3389/fgene.2023.1112744. eCollection 2023.
4
Comprehensive analysis of immune ferroptosis gene in renal clear cell carcinoma: prognosis and influence of tumor microenvironment.肾透明细胞癌中免疫铁死亡基因的综合分析：预后及对肿瘤微环境的影响
Am J Transl Res. 2022 Sep 15;14(9):5982-6010. eCollection 2022.
5
CDC20 May Serve as a Potential Biomarker-Based Risk Score System in Predicting the Prognosis of Patients with Hepatocellular Carcinoma.CDK20 可作为预测肝细胞癌患者预后的潜在基于生物标志物的风险评分系统。
Oxid Med Cell Longev. 2022 Sep 19;2022:8421813. doi: 10.1155/2022/8421813. eCollection 2022.
6
Persistent DNA damage and oncogenic stress-induced Trem1 promotes leukemia in mice.持续的 DNA 损伤和致癌应激诱导的 Trem1 促进小鼠白血病的发生。
Haematologica. 2022 Nov 1;107(11):2576-2588. doi: 10.3324/haematol.2021.280404.
7
Protein-based prognostic signature for predicting the survival and immunotherapeutic efficiency of endometrial carcinoma.基于蛋白质的预后标志物，用于预测子宫内膜癌的生存和免疫治疗效果。
BMC Cancer. 2022 Mar 25;22(1):325. doi: 10.1186/s12885-022-09402-w.
8
A united risk model of 11 immune‑related gene pairs and clinical stage for prediction of overall survival in clear cell renal cell carcinoma patients.11 对免疫相关基因与临床分期联合风险模型预测透明细胞肾细胞癌患者的总生存期。
Bioengineered. 2021 Dec;12(1):4259-4277. doi: 10.1080/21655979.2021.1955558.
9
Bioinformatics Analyses Indicate That Cathepsin G (CTSG) is a Potential Immune-Related Biomarker in Oral Squamous Cell Carcinoma (OSCC).生物信息学分析表明，组织蛋白酶G（CTSG）是口腔鳞状细胞癌（OSCC）中一种潜在的免疫相关生物标志物。
Onco Targets Ther. 2021 Feb 25;14:1275-1289. doi: 10.2147/OTT.S293148. eCollection 2021.
10
Inflammatory Markers Related to Innate and Adaptive Immunity in Atherosclerosis: Implications for Disease Prediction and Prospective Therapeutics.动脉粥样硬化中与固有免疫和适应性免疫相关的炎症标志物：对疾病预测和前瞻性治疗的意义。
J Inflamm Res. 2021 Feb 16;14:379-392. doi: 10.2147/JIR.S294809. eCollection 2021.
本文引用的文献
1
Atherosclerosis as autoimmune disease.动脉粥样硬化作为自身免疫性疾病。
Ann Transl Med. 2018 Apr;6(7):116. doi: 10.21037/atm.2018.02.02.
2
Adventitial tertiary lymphoid organ classification in human atherosclerosis.人动脉粥样硬化中血管外膜三级淋巴样器官分类。
Cardiovasc Pathol. 2018 Jan-Feb;32:8-14. doi: 10.1016/j.carpath.2017.08.002. Epub 2017 Sep 7.
3
'Trained immunity': consequences for lymphoid malignancies.“训练有素的免疫”：对淋巴系统恶性肿瘤的影响
Haematologica. 2016 Dec;101(12):1460-1468. doi: 10.3324/haematol.2016.149252. Epub 2016 Nov 10.
4
Artery Tertiary Lymphoid Organs: Powerhouses of Atherosclerosis Immunity.动脉三级淋巴器官：动脉粥样硬化免疫的强大力量
Front Immunol. 2016 Oct 10;7:387. doi: 10.3389/fimmu.2016.00387. eCollection 2016.
5
Generation of MHC class I diversity in primary tumors and selection of the malignant phenotype.原发性肿瘤中MHC I类多样性的产生及恶性表型的选择。
Int J Cancer. 2016 Jan 15;138(2):271-80. doi: 10.1002/ijc.29375. Epub 2014 Dec 13.
6
Oxidized low-density lipoprotein induces long-term proinflammatory cytokine production and foam cell formation via epigenetic reprogramming of monocytes.氧化型低密度脂蛋白通过单核细胞的表观遗传重编程诱导长期促炎细胞因子产生和泡沫细胞形成。
Arterioscler Thromb Vasc Biol. 2014 Aug;34(8):1731-8. doi: 10.1161/ATVBAHA.114.303887. Epub 2014 Jun 5.
7
Trained innate immunity and atherosclerosis.先天免疫与动脉粥样硬化的关系
Curr Opin Lipidol. 2013 Dec;24(6):487-92. doi: 10.1097/MOL.0000000000000023.
8
Local proliferation dominates lesional macrophage accumulation in atherosclerosis.局部增殖主导动脉粥样硬化病灶中巨噬细胞的积累。
Nat Med. 2013 Sep;19(9):1166-72. doi: 10.1038/nm.3258. Epub 2013 Aug 11.
9
The tumor microenvironment at a glance.肿瘤微环境概览。
J Cell Sci. 2012 Dec 1;125(Pt 23):5591-6. doi: 10.1242/jcs.116392.
10
Molecular mechanisms and clinical applications of angiogenesis.血管生成的分子机制与临床应用。
Nature. 2011 May 19;473(7347):298-307. doi: 10.1038/nature10144.
Zotero 插件